US Stock MarketDetailed Quotes

EVLO Evelo Biosciences

Watchlist
  • 0.000
  • -0.001-73.33%
15min DelayClose Nov 25 09:30 ET
7.59KMarket Cap0.00P/E (TTM)

Evelo Biosciences Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-64.24%10.39M
-39.30%17.96M
-13.36%24.9M
-6.01%108.47M
-23.48%21.09M
-11.18%29.05M
6.98%29.59M
4.61%28.74M
25.59%115.4M
-2.27%27.56M
Selling and administrative expenses
-45.40%3.89M
-41.25%4.92M
-25.21%7.04M
-5.80%29.91M
-42.35%5M
-29.52%7.13M
19.50%8.37M
57.92%9.42M
42.58%31.75M
42.61%8.68M
-General and administrative expense
-45.40%3.89M
-41.25%4.92M
-25.21%7.04M
-5.80%29.91M
-42.35%5M
-29.52%7.13M
19.50%8.37M
57.92%9.42M
42.58%31.75M
42.61%8.68M
Research and development costs
-70.36%6.5M
-38.54%13.04M
-7.58%17.86M
-6.08%78.55M
-14.81%16.08M
-2.97%21.93M
2.74%21.22M
-10.17%19.32M
20.15%83.64M
-14.62%18.88M
Operating profit
64.24%-10.39M
39.30%-17.96M
13.36%-24.9M
6.01%-108.47M
23.48%-21.09M
11.18%-29.05M
-6.98%-29.59M
-4.61%-28.74M
-25.59%-115.4M
2.27%-27.56M
Net non-operating interest income expense
-47.46%-1.16M
-34.22%-1.37M
-8.18%-1.11M
-29.35%-4.67M
-81.88%-1.84M
22.97%-788K
-25.31%-1.02M
-34.25%-1.03M
-71.27%-3.61M
-33.60%-1.01M
Non-operating interest expense
47.46%1.16M
34.22%1.37M
8.18%1.11M
29.35%4.67M
81.88%1.84M
-22.97%788K
25.31%1.02M
34.25%1.03M
71.27%3.61M
33.60%1.01M
Other net income (expense)
-34.80%-829K
-838.28%-1.54M
3,975.00%815K
83.25%-459K
-621.43%-73K
-486.79%-615K
106.80%209K
-87.65%20K
-471.27%-2.74M
-84.78%14K
Gain on sale of security
---9K
--4K
--627K
----
----
----
----
----
----
----
Special income (charges)
---793K
---1.62M
----
83.88%-520K
---520K
--0
--0
----
---3.23M
--0
-Less:Impairment of capital assets
----
--1.62M
----
----
----
----
--0
----
----
----
-Less:Other special charges
----
----
----
-83.88%520K
----
----
----
----
--3.23M
--0
-Gain on sale of property,plant,equipment
---793K
----
----
----
----
--0
----
----
----
----
Other non- operating income (expenses)
95.61%-27K
-66.99%69K
840.00%188K
-87.45%61K
3,092.86%447K
-486.79%-615K
38.41%209K
-87.65%20K
-34.15%486K
-84.78%14K
Income before tax
59.35%-12.38M
31.34%-20.87M
15.29%-25.2M
6.69%-113.6M
19.46%-23M
9.28%-30.46M
3.64%-30.4M
-5.95%-29.75M
-30.55%-121.75M
1.06%-28.56M
Income tax
-115.89%-17K
42.94%233K
25.00%145K
117.29%930K
460.82%544K
-31.41%107K
207.55%163K
-4.92%116K
4.65%428K
-48.40%97K
Net income
59.55%-12.36M
30.95%-21.1M
15.14%-25.34M
6.26%-114.53M
17.84%-23.54M
9.39%-30.56M
3.28%-30.56M
-5.91%-29.86M
-30.44%-122.18M
1.37%-28.65M
Net income continuous Operations
59.55%-12.36M
30.95%-21.1M
15.14%-25.34M
6.26%-114.53M
17.84%-23.54M
9.39%-30.56M
3.28%-30.56M
-5.91%-29.86M
-30.44%-122.18M
1.37%-28.65M
Minority interest income
Net income attributable to the parent company
59.55%-12.36M
30.95%-21.1M
15.14%-25.34M
6.26%-114.53M
17.84%-23.54M
9.39%-30.56M
3.28%-30.56M
-5.91%-29.86M
-30.44%-122.18M
1.37%-28.65M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
59.55%-12.36M
30.95%-21.1M
15.14%-25.34M
6.26%-114.53M
17.84%-23.54M
9.39%-30.56M
3.28%-30.56M
-5.91%-29.86M
-30.44%-122.18M
1.37%-28.65M
Basic earnings per share
74.91%-1.42
53.16%-3.78
58.93%-4.6
43.29%-26.2
61.11%-4.2
55.08%-5.66
31.61%-8.07
-1.82%-11.2
2.53%-46.2
12.90%-10.8
Diluted earnings per share
74.91%-1.42
53.16%-3.78
58.93%-4.6
43.29%-26.2
61.11%-4.2
55.08%-5.66
31.61%-8.07
-1.82%-11.2
2.53%-46.2
12.90%-10.8
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -64.24%10.39M-39.30%17.96M-13.36%24.9M-6.01%108.47M-23.48%21.09M-11.18%29.05M6.98%29.59M4.61%28.74M25.59%115.4M-2.27%27.56M
Selling and administrative expenses -45.40%3.89M-41.25%4.92M-25.21%7.04M-5.80%29.91M-42.35%5M-29.52%7.13M19.50%8.37M57.92%9.42M42.58%31.75M42.61%8.68M
-General and administrative expense -45.40%3.89M-41.25%4.92M-25.21%7.04M-5.80%29.91M-42.35%5M-29.52%7.13M19.50%8.37M57.92%9.42M42.58%31.75M42.61%8.68M
Research and development costs -70.36%6.5M-38.54%13.04M-7.58%17.86M-6.08%78.55M-14.81%16.08M-2.97%21.93M2.74%21.22M-10.17%19.32M20.15%83.64M-14.62%18.88M
Operating profit 64.24%-10.39M39.30%-17.96M13.36%-24.9M6.01%-108.47M23.48%-21.09M11.18%-29.05M-6.98%-29.59M-4.61%-28.74M-25.59%-115.4M2.27%-27.56M
Net non-operating interest income expense -47.46%-1.16M-34.22%-1.37M-8.18%-1.11M-29.35%-4.67M-81.88%-1.84M22.97%-788K-25.31%-1.02M-34.25%-1.03M-71.27%-3.61M-33.60%-1.01M
Non-operating interest expense 47.46%1.16M34.22%1.37M8.18%1.11M29.35%4.67M81.88%1.84M-22.97%788K25.31%1.02M34.25%1.03M71.27%3.61M33.60%1.01M
Other net income (expense) -34.80%-829K-838.28%-1.54M3,975.00%815K83.25%-459K-621.43%-73K-486.79%-615K106.80%209K-87.65%20K-471.27%-2.74M-84.78%14K
Gain on sale of security ---9K--4K--627K----------------------------
Special income (charges) ---793K---1.62M----83.88%-520K---520K--0--0-------3.23M--0
-Less:Impairment of capital assets ------1.62M------------------0------------
-Less:Other special charges -------------83.88%520K------------------3.23M--0
-Gain on sale of property,plant,equipment ---793K------------------0----------------
Other non- operating income (expenses) 95.61%-27K-66.99%69K840.00%188K-87.45%61K3,092.86%447K-486.79%-615K38.41%209K-87.65%20K-34.15%486K-84.78%14K
Income before tax 59.35%-12.38M31.34%-20.87M15.29%-25.2M6.69%-113.6M19.46%-23M9.28%-30.46M3.64%-30.4M-5.95%-29.75M-30.55%-121.75M1.06%-28.56M
Income tax -115.89%-17K42.94%233K25.00%145K117.29%930K460.82%544K-31.41%107K207.55%163K-4.92%116K4.65%428K-48.40%97K
Net income 59.55%-12.36M30.95%-21.1M15.14%-25.34M6.26%-114.53M17.84%-23.54M9.39%-30.56M3.28%-30.56M-5.91%-29.86M-30.44%-122.18M1.37%-28.65M
Net income continuous Operations 59.55%-12.36M30.95%-21.1M15.14%-25.34M6.26%-114.53M17.84%-23.54M9.39%-30.56M3.28%-30.56M-5.91%-29.86M-30.44%-122.18M1.37%-28.65M
Minority interest income
Net income attributable to the parent company 59.55%-12.36M30.95%-21.1M15.14%-25.34M6.26%-114.53M17.84%-23.54M9.39%-30.56M3.28%-30.56M-5.91%-29.86M-30.44%-122.18M1.37%-28.65M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 59.55%-12.36M30.95%-21.1M15.14%-25.34M6.26%-114.53M17.84%-23.54M9.39%-30.56M3.28%-30.56M-5.91%-29.86M-30.44%-122.18M1.37%-28.65M
Basic earnings per share 74.91%-1.4253.16%-3.7858.93%-4.643.29%-26.261.11%-4.255.08%-5.6631.61%-8.07-1.82%-11.22.53%-46.212.90%-10.8
Diluted earnings per share 74.91%-1.4253.16%-3.7858.93%-4.643.29%-26.261.11%-4.255.08%-5.6631.61%-8.07-1.82%-11.22.53%-46.212.90%-10.8
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data